Galit Levin
15Patents
12h-index
9Co-inventors
71Inventor score
Filing activity: Nov 10, 1999 → Oct 22, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7558625B2 | Combined micro-channel generation and iontophoresis for transdermal delivery of pharmaceutical agents | Human Necessities | 170 | Active |
| US7335377B2 | Transdermal delivery system for dried particulate or lyophilized medications | Human Necessities | 55 | Expired |
| US7363075B2 | Transdermal delivery system for dried particulate or lyophilized medications | Human Necessities | 39 | Expired |
| US6376545B1 | Dispersible compositions containing L-DOPA ethyl ester | Human Necessities | 35 | Expired |
| US7383084B2 | Transdermal delivery system for dried particulate or lyophilized medications | Human Necessities | 32 | Expired |
| US7395111B2 | Transdermal delivery system for water insoluble drugs | Human Necessities | 23 | Expired |
| US8041421B2 | Transdermal delivery system for polynucleotides | Human Necessities | 20 | Active |
| US7415306B2 | Transdermal delivery system for anti-emetic medication | Human Necessities | 16 | Expired |
| US7662404B2 | Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides | Human Necessities | 16 | Active |
| US6703424B2 | Dispersible compositions containing L-DOPA ethyl ester | Human Necessities | 15 | Expired |
| US9278230B2 | Electrical skin rejuvenation | Human Necessities | 15 | Active |
| US8133505B2 | Transdermal delivery system for dried particulate or lyophilized medications | Human Necessities | 15 | Active |
| US8281675B2 | Dissolution rate verification | Physics | 3 | Active |
| US8016810B2 | Transdermal delivery system for cosmetic agents | Human Necessities | 2 | Expired |
| US12380709B2 | Selecting data for deep learning | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.